For the period of 16 May 2022 to 20 May 2022 Reviewed by: Department of Health (DOH) – Health Technology Assessment Division (HTAD) Document Link: 16 to 20 May 2022
Evidence brief for 09 May – 13 May 2022
For the period of 09 May to 13 May 2022 Reviewed by: Department of Health (DOH) – Health Technology Assessment Division (HTAD) Document Link: 09 May – 13 May 2022
SOH Decision: Tocilizumab for the Treatment of COVID-19
Return to Main Page SOH approves the HTAC recommendation on tocilizumab for COVID-19 in the Philippine National Formulary (PNF) The Secretary of Health (SOH) approved the HTAC recommendation on the addition of tocilizumab for COVID-19 in the Philippine National Formulary (PNF) on 11 May 2022. On 15 March 2022, the Philippine FDA issued the CPR of tocilizumab continue reading : SOH Decision: Tocilizumab for the Treatment of COVID-19